Impact of Training Patient-centered Approach on Shared Decision in Colorectal Cancer Screening

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-06

Study Completion Date

2027-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the effect of face-to-face training of general practitioners on the implementation of a shared decision (in the context of colorectal cancer screening), versus current practice (i.e. without training in the patient-centered approach).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Teaching General Practitioners to Use the Patient-centered Approach When Suggesting Colorectal Cancer Screening

NCT03938623

Colorectal Cancer

UNKNOWN

Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

NCT01279278

Colorectal Cancer

UNKNOWN NA

Patients Navigator for Organized Colorectal Cancer Screening

NCT02369757

Healthy

COMPLETED NA

Uncovering the Barriers of Colorectal Cancer Screening Amongst Siblings of Colorectal Cancer Patients.

NCT03395938

Colorectal Cancer

COMPLETED NA

Does the Recall by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?

NCT01279330

Colorectal Cancer

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Colorectal cancer (CRC) affects 95% of cases of people aged over 50 years old with an average age of diagnosis of 71 years for men and 73 years for women with a higher prevalence in women. By the age of 75, 4 out of 100 men and 3 out of 100 women will have developed colorectal cancer.

In France, CRC screening is based on a guaiac faecal occult blood test in subjects at risk average, carried out every 2 years from 50 to 74 years old. In the event of a positive test, a colonoscopy should be performed. Participation in the programme colorectal cancer screening has been declining since 2016-2017.

The implementation of screening faces many barriers on the physian's side and/or on the patient's side. During of the last 2020-2021 screening campaign, only 6.1 million people took a screening test, which represented a participation rate of 28.9%, while it is commonly admitted that a screening rate \>50% would be necessary to reduce CRC mortality.

Some barriers are specific to CRC screening. for patient, reluctance to carry out screening, analysis of stools, and fear of cancer. For the physian, the discomfort in approaching screening and the uncertainty of the relevance of the test for some patients. The know-how and quality of information and communication with patients is at the forefront.

Physian must adapt their communication to the possibilities understanding of the subject to explain, convince, and bring the patient to carry out screening. Active listening is a technique particularly suitable for adopting a person-centred approach making it possible to take into account the patient perspectives in order to arrive at a shared decision.

This most often involves helping and giving the patient the means to manage their problems, involving them in a prevention project (non-requesting patient) or supporting them and motivating them in their approach (requesting patient).

The hypothesize of this study is that training general practitioners in a patient-centered approach will enable the implementation of greater shared decision-making work with the patient during a CRC screening presentation consultation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Screening

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patient-centered face-to-face training for General Practitioners on implementation of a shared decision

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Patient not informed of the randomization arm to which their general practitioner enrolled

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional arm

The recruited GPs will be randomized into 2 parallel groups (interventional and control). Following this randomization, the GPs from the interventional group will undergo face-to-face training to the patient-centered approach.

Group Type EXPERIMENTAL

patient-centered approach training

Intervention Type PROCEDURE

face to face training of general practitioner of interventional arm

Control arm

The GPs of the control group will take care the patient according to current screening recommendations and procedures organized by the colorectal cancer (CCR) mass screening.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

patient-centered approach training

face to face training of general practitioner of interventional arm

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 50 to 74:
* Eligible for organized CRC screening,
* Having declared as attending clinician a general practitioner investigator of the study

✓ Consulting their attending clinician for the duration of the study,
* AND able and willing to comply with all trial requirements

\- ✓ Screened for CRC less than 2 years ago

* Not eligible for organized CRC screening:

* History of adenomas or CRC:

\- Family (1st degree)
* Personal history of IBD:

* Crohn's disease
* Ulcerative colitis)
* Hereditary predispositions:

* Familial adenomatous polyposis
* Hereditary non-polyposis colorectal cancer (Lynch syndrome)
* Patient with symptoms requiring colonoscopy
* Having a level of literacy that does not allow the completion of the self-questionnaire.
* Having an inability to give express consent.
* Being under guardianship, curatorship or having cognitive disorders

Minimum Eligible Age

50 Years

Maximum Eligible Age

74 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No